|| powered by |
New MDC Research Report Published08.05.2014 - (idw) Max-Delbrück-Centrum für Molekulare Medizin (MDC) Berlin-Buch
The new biannual research report for the years 2012 and 2013 of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch has now been published. In the 326-page report, which is predominantly in English, the 62 research groups of the MDC, the central units (technology platforms) and the clinical groups in the Experimental and Clinical Research Center (ECRC) of the MDC and the Charité Universitätsmedizin Berlin give an overview of their work in the research areas of cardiovascular and metabolic diseases, cancer, diseases of the nervous system and systems biology.
In his introduction to the research report, Professor Walter Rosenthal, MDC board chairman and scientific director, noted that the MDC had received the best possible mark of outstanding in its evaluation by international reviewers in 2012. At the same time the course was set for the further development of the MDC and its deeper integration into research activities on the state and federal level.
In his introductory remarks, Professor Rosenthal highlighted the Berlin Institute of Health (BIH), which was founded in 2013. The MDC and the Charité have cooperated since 1992 in translational research the transfer of findings of basic research to applications in the clinic. With the new Berlin Institute of Health which has a thematic focus on systems medicine, the MDC and the Charité will substantially expand this cooperation. Furthermore, in 2012 the German Center for Cardiovascular Research (DZHK), in which the MDC participates, was opened. It is one of a total of six German Centers for Health Research (DZG) which the Federal Ministry of Education and Research has established.
In 2012 plans were confirmed for the opening of a second location of the MDC in the heart of Berlin. The Berlin Institute for Medical Systems Biology (BIMSB) of the MDC is expected to move into a new building on the North Campus of the Humboldt-Universität (HU) in Berlin-Mitte in 2018. Together with the HU and the Charité, the MDC founded the Integrative Research Institute (IRI) for the Life Sciences, which will also be established on HUs North Campus.
The MDC was founded on Campus Berlin-Buch in 1992. It is a member of the Helmholtz Association of German Research Centres and receives its basic operational funding of approximately 68 million euros a year in a fixed ratio of 90 percent from the Federal Ministry of Education and Research and 10 percent from the state of Berlin. In addition, extramural grants acquired by the researchers are in the two-digit million-euro range each year. At present (as of April 2014), 1615 people from 58 countries work at the MDC, among them 461 scientists and 371 doctoral students.
To receive this research report, please request a copy from the MDC Press Department.
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
in the Helmholtz Association
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
HTML-Code zum Verweis auf diese Seite:
<a href="http://www.uni-protokolle.de/nachrichten/id/277756/">New MDC Research Report Published </a>